Adverse Drug Reaction
24
3
4
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 24 trials
100.0%
+13.5% vs benchmark
8%
2 trials in Phase 3/4
7%
1 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (24)
The Texas Interprofessional Pharmacogenomics (IPGx)
Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure
Personalised Therapeutics @LUMC
Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions
Educational Intervention in Pharmacovigilance for Hospital Health Professionals
Reducing Costs by Deprescribing Medications
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Drug Interactions in Outpatients.
Pharmacists' Knowledge and Attitudes About ADRs Reporting and Pharmacovigilance Practice in Egyptian Hospitals
Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
Evaluating ActionADE in Reducing Adverse Drug Reactions
Deprescribing of Symptomatic Medications in Rehabilitative or Subacute Care Patients
Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
Serious Adverse Drug Reaction and Their Preventability
Adverse Drug Reactions With Fatal Outcome
The Drug Induced Renal Injury Consortium
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study